Few with type 2 diabetes receive guideline-recommended CKD screening
Jul 01, 2024
24.9 percent received creatinine and UACR screening; Hispanic ethnicity associated with lack of screening
Triglyceride-glucose index independently linked to all-cause mortality
Jun 21, 2024
Association with in-hospital and one-year mortality seen for patients with heart failure and chronic kidney disease
AI screens patients for clinical trials with greater accuracy than staff
Jun 20, 2024
In addition to enhanced performance, automated screening cuts costs.
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.
Prevalence of cardiovascular risk factors, diseases set to increase
Jun 06, 2024
The annual inflation-adjusted health care costs of cardiovascular risk factors is projected to triple between 2020 and 2050.
No decline in cardiovascular events seen with COVID-19 vaccine after acute coronary syndromes
Jun 03, 2024
Findings show no significant reduction in primary end point, MACE for those receiving vaccine after acute coronary syndromes
Semaglutide reduces need for diuretics in heart failure
May 16, 2024
Medication also has a beneficial effect on the change in body weight across diuretic use categories.
Gains in heart failure mortality have been erased
Apr 26, 2024
The declines seen in heart failure mortality rates from 1999 to 2012 were reversed from 2012 to 2021.
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Risk for adverse outcomes increased with antipsychotic use in dementia
Apr 19, 2024
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia and acute kidney injury.